Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody

Pain

Volumn 69, Issue 1-2, 1997, Pages 145-151

  Xiao, Wen Hua ^a   Yu, Alice L ^b   Sorkin, Linda S ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Allodynia; Anti GD2 antibody; GD2 ganglioside; Pain background activity; Peripheral sensitization

Indexed keywords

GANGLIOSIDE GD2; LIDOCAINE; MONOCLONAL ANTIBODY;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SENSITIZATION; SENSORY NERVE;

ANESTHETICS, LOCAL; ANIMALS; ANTIBODIES, MONOCLONAL; BEHAVIOR, ANIMAL; ELECTROPHYSIOLOGY; GANGLIOSIDES; HUMANS; LIDOCAINE; MALE; MECHANORECEPTORS; MICE; NEURONS, AFFERENT; NOCICEPTORS; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031056936     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03280-0     Document Type: Article

References (26)

1. Bach, F.W., Jensen, T.S., Kastrup, J., Stigsby, B. and Dejgard, A., The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy, Pain, 40 (1990) 29-34.
2. Brown, A. and Iggo, A., A quantitative study of the cutaneous receptors and afferent fibres in the cat and rabbit, J. Physiol., 193 (1967) 707-733.
3. Bumol, T.F. and Reisfeld, R.A., Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells, Proc. Natl. Acad. Sci. USA, 79 (1982) 1245-1249.
4. Cassuto, J., Wallin, G., Hogstrom, S., Faxen, A. and Rimback, G., Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine, Anesth. Analg., 64 (1985) 971-974.
5. Chabal, C., Russell, L. and Burchiel, K., The effect of intravenous lidocaine, tocainide and mexiletine on spontaneously active fibers originating in rat sciatic neuromas, Pain, 38 (1989) 333-338.
6. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. and Yaksh, T.L., Quantitative assessment of tactile allodynia in the rat paw, J. Neurosci. Methods, 53 (1994) 55-63.
7. Chen, Y., Potter, J. and Ravenscroft, P., A quick sensitive high-performance liquid chromatography assay for monoethylglycinexylidide and lignocaine in serum/plasma using solid-phase extraction, Ther. Drug Monit., 14 (1992) 317-321.
8. Cheung, N., Lazarus, H., Miraldi, F., Abramowsky, C., Kallick, S., Saarinen, U., Spitzer, T., Strandjord, S., Coccia, P. and Berger, N., Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma, J Clin. Oncol., 5 (1987) 1430-1440.
9. Davis, K., Meyer, R. and Campbell, J., Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey, J. Neurophysiol., 69 (1993) 1071-1081.
10. Devor, M., Wall, P.D. and Catalan, N., Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction, Pain, 48 (1992) 261-268.
11. Dixon, W., Efficient analysis of experimental observations, Annu. Rev. Pharmacol. Toxicol., 20 (1980) 441-462.
12. Gillies, S.D., Lo, K.M. and Wesolowski, J., High level expression of chimeric antibodies using adapted cDNA variable region cassettes, J. Immunol. Methods, 125 (1989) 191-202.
13. Hille, B., Ionic Channels of Excitable Membranes, Sinauer, Sunderland, MA, 1984.
14. Hua, X.-Y., Chen, P., Fox, A. and Myers, R., Involvement of cytokines in lipopolysaccaride-induced facilitation of CGRP release from capsaicin sensitive nerves in the trachea: studies with IL-β and TNF-α, J. Neurosci., (1996) in press.
15. Kajander, K., Waikaka, S. and Bennett, G., Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat, Neurosci. Lett., 138 (1992) 225-228.
16. Lorec, A., Bruguerolle, B., Attolinin, L. and Roucoules, X., Rapid simultaneous determination of lidocaine, bupivacaine, and their two main metabolites using capillary gas-liquid chromatography with nitrogen phosphorous detector, Ther. Drug Monit., 16 (1994) 592-595.
17. Mujoo, K., Kipps, T.J., Yang, H.M., Cheresh, D.A., Wargalla, U., Sander, D.J. and Reisfeld, R.A., Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18, Cancer Res., 49 (1989) 2857-2861.
18. Puig, S. and Sorkin, L.S., Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase 2 activity, Pain, 64 (1996) 345-355.
19. Reeh, P., Bayer, J., Kocher, L. and Handwerker, H., Sensitization of nociceptive cutaneous nerves from the rat's tail by noxious mechanical stimulation, Exp. Brain Res., 65 (1987) 505-512.
20. Rowbotham, M.C., Reisner-Keller, L. and Fields, H., Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia, Neurology, 41 (1991) 1024-1028.
21. Schultz, G., Cheresh, D., Varki, N., Yu, A., Staffileno, L. and Reisfeld, R.A., Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients, Cancer Res., 44 (1984) 5914-5920.
22. Slart, R., Yu, A.L., Yaksh, T.L. and Sorkin, L.S., An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody, Pain, 69 (1996) 119-125.
23. Svennerholm, L., Gangliosides - a new therapeutic agent against stroke and Alzheimer's disease, Life Sci., 55 (1994) 2125-2134.
24. Svennerholm, L., Boström, K., Fredman, P., Jungbejer, B., Lekman, A. and Månsson, J.-E., Gangliosides and allied glycosphyngolipids in human peripheral nerve and spinal cord, Biochim. Biophys. Acta, 1214 (1994) 115-123.
25. Tanelian, D. and Mclver, B., Analgesic concentrations of lidocaine suppress tonic Aδ and C fiber discharges produced by acute injury, Anesthesiology, 74 (1991) 934-936.
26. Wallace, M., Sorkin, L.S., Lee, J., Laitin, S., Yu, A., Dunn, J. and Yaksh, T.L., Effect of pretreatment with lidocaine on pain following anti-GD2 ganglioside antibody for neuroblastoma, Am. Pain Soc. Abstr., 14 (1995) A109.